期刊文献+

蛇床子素对TRAIL抗乳腺癌活性的影响及其作用机制 被引量:3

Effect of Osthole on the Anti-breast Cancer Activity of TRAIL and Its Mechanism
原文传递
导出
摘要 目的探讨中药活性成分蛇床子素对抗肿瘤药物TRAIL抗乳腺癌活性的影响并研究其机制。方法用蛇床子素联合TRAIL体外治疗乳腺癌细胞系BT-20,MTT法检测肿瘤细胞的细胞活力,Annexin V/PI染色检测肿瘤细胞的凋亡,免疫共沉淀法检测RIP1-FADD-caspase-8复合物的形成。Western blot法检测BT-20细胞caspase-8的活化及蛇床子素对BT-20细胞c IAP2蛋白表达的影响。结果联用蛇床子素显著提高TRAIL对BT-20细胞活力的抑制率和凋亡诱导活性。免疫共沉淀及Western blot结果发现联合蛇床子素后,TRAIL治疗的BT-20细胞内的RIP1-FADD-caspase-8复合物水平及caspase-8的活化程度显著提高。Western blot结果发现蛇床子素对BT-20细胞内的c IAP2蛋白表达有抑制作用。在BT-20细胞中转染c IAP2表达质粒后,蛇床子素对TRAIL抗肿瘤活性的促进作用受到抑制。结论蛇床子素通过促进死亡受体复合物的形成增强TRAIL对乳腺癌细胞的凋亡诱导效应。 OBJECTIVE To investigate the effect of osthole on the anti-breast cancer activity of TRAIL and study its mechanism. METHODS After the BT-20 cells were treated with TRAIL combined with osthole, the cell viability, cell apoptosis, and the formation of RIP1-FADD-caspase-8 complex were detected by MTT assay, Annexin Ⅴ/PI staining, and co-immunoprecipitation, respectively. The activation of caspase-8 and the expression of c IAP2 in BT-20 cells were evaluated by Western blot assay. RESULTS Addition of osthole significantly enhanced the cell viability inhibition rate and apoptosis inducing activity in BT-20 cells treated with TRAIL. The results of co-immunoprecipitation and Western blot indicated that the formation of RIP1-FADD-caspase-8 complex and the activation of caspase-8 in TRAIL-treated BT-20 cells were significantly increased due to the combination of osthole. The results of Western blot assay demonstrated that the expression of c IAP2 could be significantly inhibited due to the osthole treatment. Moreover, the transfection of c IAP2 vector abolished the promotion of osthole on TRAIL-induced cell death in BT-20 cells. CONCLUSION Osthole promotes TRAIL-induced apoptosis by the formation of RIP1-FADD-caspase-8 complex in breast cancer.
机构地区 丽水市人民医院
出处 《中国现代应用药学》 CAS CSCD 2016年第9期1141-1147,共7页 Chinese Journal of Modern Applied Pharmacy
关键词 蛇床子素 TRAIL 乳腺癌 CASPASE-8 凋亡 osthole TRAIL breast cancer caspase-8 apoptosis
  • 相关文献

参考文献17

  • 1SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013, 63(1): 11-30.
  • 2HUANG X E, WANG L, LI L, et al. Safety of Lienal Polypeptide injection combined with chemotherapy in treating patients with advanced cancer [J]. Asian Pac J Cancer Prey, 2015, 16(17): 7837-7841.
  • 3KIM B, STEPHEN S L, HUGHES T A, et al. Chemotherapy induces Notchl-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy [J]. BMC Cancer, 2015, 15(1): 634-645.
  • 4LAUSSMANN M A, PASSANTE E, REHM M, et al. Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling [J]. J Biol Chem, 2012, 287(18): 14402-14411.
  • 5HARI Y, HARASHIMA N, HARADA M, et al. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL [J]. Oncotarget, 2015, 6(39): 41902-41915.
  • 6AMARANTE-MENDES G P, GRIFFITH T S. Therapeutic applications of TRAIL receptor agonists in cancer and beyond [J]. Pharmacol Ther, 2015(155): 117-131.
  • 7TRIVEDI R, MISHRA D P. Trailing TRAIL resistance: Novel targets for TRAIL sensitization in cancer cells [J]. Front Oncol, 2015(5): 69-88. Doi: 10.3389/fonc.2015.00069.
  • 8F1NLAY D, VAMOS M, VUORI K, et al. Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and clAPs [J]. Mol Cancer Ther, 2014, 13(1): 5-15.
  • 9BALAYSSAC S, GILARD V, MALET-MARTINO M, et al. Analysis of herbal dietary supplements for sexual performance enhancement: first characterization of propoxyphenyl- thiohydroxyhomosildenafil and identification of sildenafil, thiosildenafil, phentolamine and tetrahydropalmatine as adulterants [J]. J Pharm Biomed Anal, 2012(63): 135-150.
  • 10LIN K, GAO Z, FU Q, et al. Osthole suppresses the proliferation and accelerates the apoptosis of human glioma cells via the upregulation of microRNA-16 and downregulation of MMP-9 [J]. Mol Med Rep, 2015, 12(3): 4592-4597.

二级参考文献5

共引文献6

同被引文献31

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部